Web10 jan. 2024 · DUBLIN, Jan. 10, 2024 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced that it has entered into a definitive … Web10 jan. 2024 · Medtronic has announced that it has entered into an agreement to acquire medical technology company Affera. Affera designs and manufactures cardiac mapping and navigation systems and catheter-based cardiac ablation technologies, including a differentiated, focal pulsed field ablation (PFA) solution, for the treatment of patients with …
Medtronic completes patient recruitment in Sphere-9 ablation …
Web10 jan. 2024 · Today Medtronic announced its entrance into a definitive agreement to acquire privately held, Boston-based Affera, Inc. The company designs and manufactures cardiac mapping and navigation systems, and catheter-based cardiac ablation technologies. WebAffera is a medical technology company dedicated to developing innovative solutions for the treatment of cardiac arrhythmia. Search Crunchbase. ... Affera, Inc. was acquired by Medtronic for $925M on Jan 10, 2024. Transaction Name . Affera, Inc. acquired by Medtronic . Acquired by . Medtronic . Announced Date Jan 10, 2024; Price $925M; organize itunes music library
MEDTRONIC ERHÄLT CE-KENNZEICHNUNG FÜR DAS AFFERA™ …
Web30 aug. 2024 · In January, Medtronic announced an agreement to acquire Affera, with CEO Geoff Martha labeling the deal as a nearly $1 billion transaction at the J.P. Morgan Healthcare Conference, adding that... Web17 mrt. 2024 · Medtronic plc MDT recently announced the receipt of a CE Mark for the Affera Mapping and Ablation System to treat atrial arrhythmias. The system includes the Sphere-9 Catheter and the Affera... Web20 dec. 2024 · The Affera system includes the Sphere-9 catheter and integrated Prism-1 mapping system to enable the rapid creation of detailed maps, as well as the versatile HexaGEN ablation system to deliver either pulsed field or radiofrequency lesion sets in a variety of substrates. how to use pulse desktop microphone